- Why You Should Register?
- 2020 ARCHIVES
Diversity, inclusion and equity in clinical trials has been an ongoing issue in clinical trials despite numerous calls to action. In this session SCRS, FDA and industry representatives will discuss the critical importance of this issue specifically as it impacts the clinical research site. The ongoing work of the SCRS diversity project will be high lighted along with the launch of the industry standard that has been validated and designed by the working group, to measure and assess the sites individual assessment of best practices in diversity.